ArticleAbdominal radiology (New York)2025
Assessment of endometrial cancer with microcystic, elongated, and fragmented pattern invasion using multiparametric MRI.
Article in Abdominal radiology (New York), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo assess the MRI findings of endometrial cancer with microcystic, elongated, and fragmented (MELF) pattern invasion and to evaluate the optimal sequences to detect deep myometrial invasion with MELF. MATERIALS AND
methodsThis retrospective single-center case-control study included 85 patients with endometrial cancer, including 17 patients with MELF, between December 2020 and January 2023. Preoperative MRI, including T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), and dynamic contrast-enhanced (DCE) with equilibrium phase contrast-enhanced (CE) MRI were reviewed by three radiologists. DWI signal gradation with DWI-CE mismatch (DG-DCM) and tumor-myometrium synchronous early enhancement (TME) were evaluated, as well as the diagnostic performance for deep myometrial invasion, first with T2WI + CE alone and then with the addition of DWI + DCE. Pathology was used as the reference standard.
resultsThe sensitivity and specificity of DG-DCM were 41.2-76.5% and 89.7-98.5%, and those of TME were 70.7-82.4% and 94.1-95.6%, respectively, for MELF by the three readers. For the diagnosis of deep myometrial invasion with MELF, the addition of DWI + DCE to T2WI + CE significantly improved the sensitivity for two readers (from 16.7 to 91.7% for Reader 1, from 16.7 to 83.3% for Reader 2, p < 0.01) and the accuracy for one reader (from 35.3 to 82.4% for Reader 1, p < 0.01). In contrast, sensitivity, specificity and accuracy did not change with the addition of DWI + DCE in tumors without MELF.
conclusionEndometrial cancer with MELF may show characteristic MRI findings of DG-DCM and TME. The value of DWI and DCE in detecting deep myometrial invasion may be high for MELF pattern invasion.
Indexed as
Identifiers
40237809What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.